CRTH2 antagonists (Abbott)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCRTH2 antagonists (Abbott)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonistsProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomeraseProstaglandin D2 receptor 2
Therapy Area/IndicationsInflammationRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsInflammationRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A